Sharon Hensley Alford, PhD
Articles
November 20th 2012
Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study
Katrina A.B. Goddard, PhD Erin J. Aiello Bowles, MPH Heather Spencer Feigelson, PhD, MPH Laurel A. Habel, PhD Sharon Hensley Alford, PhD Catherine A. McCarty, PhD, MPH Larissa Nekhlyudov, MD, MPH Adedayo A. Onitilo, MD, MSCR, FACP Alanna K. Rahm, PhD, MS Jennifer A. Webster, MS
Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 16th 2024 | Updated: September 18th 2024
Healing Wounds Through Peer Support
Published: September 3rd 2024 | Updated: September 18th 2024
Dr JT Lew Explores the Barriers to MS Medication Access
Published: August 6th 2024 | Updated: September 18th 2024
Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden
Published: August 16th 2024 | Updated: September 18th 2024
How Can We Improve Obesity Care in 2024 and Beyond?
Published: September 12th 2024 | Updated: September 18th 2024
The American Journal of Managed Care® Announces Lisa Rotenstein, M.D., MBA, as the Recipient of the Seema S. Sonnad Emerging Leader in Managed Care Research Award
